Sulfatrim Suspension
FDA Label NDC 68788-7345

50 label sections · Submitted to the FDA by Preferred Pharmaceuticals, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Preferred Pharmaceuticals, Inc. for the product Sulfatrim (NDC 68788-7345). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding sulfatrim - sulfamethoxazole and trimethoprim suspension, description, clinical pharmacology, geriatric pharmacokinetics, microbiology, indications and usage, urinary tract infections, acute otitis media, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.